Compare stocks
Add stockDates End of financial period
| #1 | #2 | #3 | #4 | #5 | #6 | #7 | #8 | |
|---|---|---|---|---|---|---|---|---|
| Remove AbbVie Inc. | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 |
Profit ROIC / ROE/ROA / ROE / ROA
| #1 | #2 | #3 | #4 | |
|---|---|---|---|---|
| AbbVie Inc. (ROIC) | 19.1% | 16.0% | 15.6% | 14.3% |
Growth Sales and OCF growth / Sales and net income growth
| #1 | #2 | #3 | #4 | |
|---|---|---|---|---|
| AbbVie Inc. | 6.7% | 16.0% | 5.6% | 13.8% |
Payout Shareholder distributions / net income
| #1 | #2 | #3 | #4 | #5 | |
|---|---|---|---|---|---|
| AbbVie Inc. | 240% | 338% | 294% | 378% | 288% |
Safety Equity/assets and OCF stability / Equity/assets and net income stability
| Balance | Stability | |
|---|---|---|
| AbbVie Inc. | -3.0% | 78.1% |
Price Earnings and FCF yield / Earnings and book yield
| Earnings | FCF / Book | |
|---|---|---|
| AbbVie Inc. | $1.35 | $3.90 |
